drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy

Other Services
Reprints / E-Prints
Submit News
White Papers

Retail News Breaks Archives

Week of   

Week of Mon, Nov 22nd, 2010

Study warns of big changes in Medicare Part D plans

Medicare patients need to be aware of significant formulary changes when choosing a prescription drug plan for next year, according an Avalere Health study of 2011 Medicare Part D plans.

Cardinal names new exec to head Medicine Shoppe

John Fiacco has been appointed vice president of Medicine Shoppe and Medicap Pharmacies and will take over leadership of both drug store franchises from Terry Burnside, who has stepped down, according to Cardinal Health Inc.

NACDS: Accountable care groups should include pharmacists

Pharmacy can play a key role in accountable care organizations (ACOs), which seek to improve health care quality and control costs for patients, according to the National Association of Chain Drug Stores.

Diabetes patients struggle to pay for supplies, poll finds

More than 50% of people with diabetes are finding it a struggle to afford diabetic supplies, according to a survey by diabetes community network dLife.

London Drugs serves up photo gift software

London Drugs is offering software that enables customers to create photo books on their home computers.

Coalition calls for repeal of 'cough and cold tax'

A broad coalition of industry groups representing retail pharmacies and makers of over-the-counter drugs is urging Congress to nullify a new health care reform requirement that would prevent consumers from using flexible spending accounts (FSAs) to buy nonprescription medicines.

Walgreens oral oncology program sizes up savings

Walgreen Co. reported that an analysis of more than 1,700 patients in its Walgreens Specialty Pharmacy oncology cycle management program (CMP) showed potential savings of $3 million in first three months of therapy.

Shoppers Drug Mart responds to class-action suit

Shoppers Drug Mart Corp. said two of its licensed associate-owners have filed a $1 billion class-action lawsuit against the company.